Review Article
The Effect and Safety of 5-HT1F Receptor Agonist Lasmiditan on Migraine: A Systematic Review and Meta-Analysis
Figure 5
Forest plot: the proportion of migraineurs reporting TEAE (at least one) in the lasmiditan group (50 mg, 100 mg, and 200 mg) versus placebo after the first dose.